Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection.

Oh HS, Eom DW, Kang GH, Ahn YC, Lee SJ, Kim JH, Jang HJ, Kim EJ, Oh KH, Ahn HJ.

Gastric Cancer. 2014;17(3):402-11. doi: 10.1007/s10120-013-0288-0. Epub 2013 Aug 17.

PMID:
23955257
2.

Is Helicobacter pylori a poor prognostic factor for HER-2 SISH positive gastric cancer?

Selcukbiricik F, Tural D, Erdamar S, Buyukunal E, Demirelli F, Serdengecti S.

Asian Pac J Cancer Prev. 2013;14(5):3319-22.

3.

Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?

Selcukbiricik F, Erdamar S, Buyukunal E, Serrdengecti S, Demirelli F.

Asian Pac J Cancer Prev. 2014;15(24):10607-11.

4.

Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer.

Terashima M, Kitada K, Ochiai A, Ichikawa W, Kurahashi I, Sakuramoto S, Katai H, Sano T, Imamura H, Sasako M; ACTS-GC Group.

Clin Cancer Res. 2012 Nov 1;18(21):5992-6000. doi: 10.1158/1078-0432.CCR-12-1318. Epub 2012 Sep 12.

5.

Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.

He C, Bian XY, Ni XZ, Shen DP, Shen YY, Liu H, Shen ZY, Liu Q.

World J Gastroenterol. 2013;19(14):2171-8. doi: 10.3748/wjg.v19.i14.2171.

6.

Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery.

Galizia G, Lieto E, Orditura M, Castellano P, Mura AL, Imperatore V, Pinto M, Zamboli A, De Vita F, Ferraraccio F.

World J Surg. 2007 Jul;31(7):1458-68.

PMID:
17516110
7.

Impact of HER-2 overexpression/amplification on the prognosis of gastric cancer patients undergoing resection: a single-center study of 1,036 patients.

Hsu JT, Chen TC, Tseng JH, Chiu CT, Liu KH, Yeh CN, Hwang TL, Jan YY, Yeh TS.

Oncologist. 2011;16(12):1706-13. doi: 10.1634/theoncologist.2011-0199. Epub 2011 Dec 5.

8.

HER2 expression and its clinicopathological features in resectable gastric cancer.

Kataoka Y, Okabe H, Yoshizawa A, Minamiguchi S, Yoshimura K, Haga H, Sakai Y.

Gastric Cancer. 2013 Jan;16(1):84-93. doi: 10.1007/s10120-012-0150-9. Epub 2012 Mar 14.

PMID:
22410801
9.

The significance of the HER-2 status in esophageal adenocarcinoma for survival: an immunohistochemical and an in situ hybridization study.

Prins MJ, Ruurda JP, van Diest PJ, van Hillegersberg R, Ten Kate FJ.

Ann Oncol. 2013 May;24(5):1290-7. doi: 10.1093/annonc/mds640. Epub 2013 Jan 18.

10.

HER-2/neu overexpression is an independent prognostic factor for intestinal-type and early-stage gastric cancer patients.

Liu W, Zhong S, Chen J, Yu Y.

J Clin Gastroenterol. 2012 Apr;46(4):e31-7. doi: 10.1097/MCG.0b013e31823457ea.

PMID:
22064554
11.

Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites.

Gumusay O, Benekli M, Ekinci O, Baykara M, Ozet A, Coskun U, Demirci U, Uner A, Dursun A, Atak EY, Buyukberber S.

Jpn J Clin Oncol. 2015 May;45(5):416-21. doi: 10.1093/jjco/hyv020. Epub 2015 Mar 2.

12.

HER2 status in gastro-oesophageal adenocarcinomas assessed by two rabbit monoclonal antibodies (SP3 and 4B5) and two in situ hybridization methods (FISH and SISH).

Boers JE, Meeuwissen H, Methorst N.

Histopathology. 2011 Feb;58(3):383-94. doi: 10.1111/j.1365-2559.2011.03760.x. Epub 2011 Feb 16.

13.

HER2 status in gastric cancer: a comparison of two novel in situ hybridization methods (IQ FISH and dual color SISH) and two immunohistochemistry methods (A0485 and HercepTest™).

Pala EE, Bayol U, Ozguzer A, Akman O.

Pathol Res Pract. 2013 Sep;209(9):548-54. doi: 10.1016/j.prp.2013.05.008. Epub 2013 Jun 27.

PMID:
23910175
14.

HER-2/neu amplification is an independent prognostic factor in gastric cancer.

Park DI, Yun JW, Park JH, Oh SJ, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI, Yoo CH, Son BH, Cho EY, Chae SW, Kim EJ, Sohn JH, Ryu SH, Sepulveda AR.

Dig Dis Sci. 2006 Aug;51(8):1371-9. Epub 2006 Jul 26.

PMID:
16868827
15.

Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patients.

Al-Saad S, Al-Shibli K, Donnem T, Andersen S, Bremnes RM, Busund LT.

J Thorac Oncol. 2010 Oct;5(10):1536-43. doi: 10.1097/JTO.0b013e3181ea510a.

16.

A large cohort of consecutive patients confirmed frequent HER2 positivity in gastric carcinomas with advanced stages.

Cho J, Jeong J, Sung J, Sung CO, Kim KM, Park CK, Choi MG, Sohn TS, Bae JM, Kim S.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S477-84. doi: 10.1245/s10434-012-2818-0. Epub 2012 Dec 30.

PMID:
23274580
17.

Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.

Begnami MD, Fukuda E, Fregnani JH, Nonogaki S, Montagnini AL, da Costa WL Jr, Soares FA.

J Clin Oncol. 2011 Aug 1;29(22):3030-6. doi: 10.1200/JCO.2010.33.6313. Epub 2011 Jun 27.

18.

Prognostic impact of major receptor tyrosine kinase expression in gastric cancer.

Kurokawa Y, Matsuura N, Kawabata R, Nishikawa K, Ebisui C, Yokoyama Y, Shaker MN, Hamakawa T, Takahashi T, Takiguchi S, Mori M, Doki Y.

Ann Surg Oncol. 2014 Dec;21 Suppl 4:S584-90. doi: 10.1245/s10434-014-3690-x. Epub 2014 Apr 18.

PMID:
24743909
19.

Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.

Nagatsuma AK, Aizawa M, Kuwata T, Doi T, Ohtsu A, Fujii H, Ochiai A.

Gastric Cancer. 2015 Apr;18(2):227-38. doi: 10.1007/s10120-014-0360-4. Epub 2014 Mar 14.

PMID:
24626858
20.

Prognostic value of epidermal growth factor receptors in gastric cancer: a survival analysis by Weibull model incorporating long-term survivors.

Jácome AA, Wohnrath DR, Scapulatempo Neto C, Carneseca EC, Serrano SV, Viana LS, Nunes JS, Martinez EZ, Santos JS.

Gastric Cancer. 2014 Jan;17(1):76-86. doi: 10.1007/s10120-013-0236-z. Epub 2013 Feb 28.

Items per page

Supplemental Content

Write to the Help Desk